Martin R. Farlow

Martin R. Farlow, Professor Emeritus in the Department of Neurology at Indiana University and co-director of the Alzheimer’s Disease Center at Indiana University, will serve as chair of the SAB. Dr. Farlow received his medical degree from Indiana University School of Medicine. Following graduation, he completed an internship in Internal Medicine and a residency in Neurology.

Dr. Farlow’s research focuses on clinical trials of investigational drugs for the treatment of AD and related dementias and has been the lead investigator for several major studies including tacrine, donepezil and rivastigmine. Dr. Farlow has authored numerous peer reviewed scientific publications and lectured on the topics of aging, dementia, and Alzheimer’s disease at more than 300 meetings, conferences, and hospitals/medical schools throughout the world. He is a reviewer for numerous scientific journals and on the editorial boards of MedLink and Current Alzheimer Research. Dr. Farlow is a member of many professional associations including the American Academy of Neurology and the American Neurological Association. He is also a founding member of both the American Society of Experimental Neurotherapeutics and the International Society for CNS Clinical Trials and Methodology.